Luoxin Pharmaceuticals Group Co., Ltd. (002793)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
5. 28
-0.02
-0.3774%
¥
5.82B Market Cap
- P/E Ratio
0.12% Div Yield
60.24M Volume
- Eps
¥ 5.3
Previous Close Want to track 002793 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
002793 closed today lower at ¥5.28, a decrease of -0.3774% from yesterday's close, completing a monthly increase of 37.5% or ¥1.44. Over the past 12 months, 002793 stock gained 10%.
002793 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0.0052%. On average, the company has fell short of earnings expectations by -0.0652%, based on the last three reports.
Luoxin Pharmaceuticals Group Co., Ltd. has completed 2 stock splits, with the recent split occurring on Sep 23, 2019.
The company's stock is traded on one exchange.
Luoxin Pharmaceuticals Group Co., Ltd. (002793) FAQ
What is the stock price today?
The current price is ¥5.28.
On which exchange is it traded?
Luoxin Pharmaceuticals Group Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 002793.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.12%.
What is its market cap?
As of today, the market cap is 5.82B.
Has Luoxin Pharmaceuticals Group Co., Ltd. ever had a stock split?
Luoxin Pharmaceuticals Group Co., Ltd. had 2 splits and the recent split was on Sep 23, 2019.
Luoxin Pharmaceuticals Group Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Zhenteng Liu CEO | XSHE Exchange | CNE1000026S7 ISIN |
| CN Country | 3,196 Employees | 13 May 2022 Last Dividend | 1 Jun 2017 Last Split | - IPO Date |
Overview
Luoxin Pharmaceuticals Group Stock Co., Ltd. is a prominent player in China's pharmaceutical industry, focusing primarily on the research and development, production, and trading of pharmaceutical products. With its foundation laid in 1998, originally operating under the name Zhejiang Doyin Pump Industry Co., Ltd., the company underwent a significant transformation and rebranded itself as Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Based in Linyi, China, Luoxin Pharmaceuticals has built a reputation for its extensive array of pharmaceutical solutions, catering to various medical needs and advancing healthcare services in China and potentially beyond.
Products and Services
Luoxin Pharmaceuticals offers a comprehensive catalogue of pharmaceutical products and services designed to meet a wide range of healthcare requirements:
- Antiviral APIs and Intermediates: Focused on combating viral infections, these active pharmaceutical ingredients (APIs) and intermediates are crucial for developing antiviral medications.
- Anti-infective APIs and Intermediates: These products are essential for creating drugs that fight infectious diseases, helping reduce the global burden of such ailments.
- Respiratory and Digestive System Pharmaceuticals: Tailored for conditions affecting the respiratory and digestive systems, these medications support patient recovery and manage chronic conditions.
- Nervous and Endocrine System Pharmaceuticals: Addressing disorders related to the nervous and endocrine systems, these drugs play a critical role in managing brain health and hormonal balances.
- Cardiovascular System Pharmaceuticals: Crucial for treating heart and blood vessel diseases, these medications aim to improve heart health and reduce the risk of cardiovascular events.
- Oncology Pharmaceuticals: Focused on cancer treatment, these products offer hope and care for patients fighting various types of cancer.
- Anti-allergic APIs and Intermediates: Designed to counter allergic reactions, these ingredients are key in producing antihistamines and other allergy medications.
- Antipyretic, Analgesics, and Anti-inflammatory APIs and Intermediates: These products are essential for developing fever reducers, pain relievers, and medications to control inflammation, addressing a wide range of conditions.
- Medical Treatment and Health Care Services: Beyond pharmaceuticals, Luoxin Pharmaceuticals extends its expertise to providing medical treatment services and comprehensive health care solutions, demonstrating its commitment to improving patient care and health outcomes.
Contact Information
Address: No. 18, Huxi Road, Linyi, China, 276017
Phone: 86 53 9824 1226
Website: https://www.luoxin.cn
